erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

"the treatment of our family and the behaviour of the western trust has been disgraceful, they should be ashamed of themselves.. november 2014  (25).